Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Oric Pharmaceuticals, Inc. | Chief Financial Officer | Common Stock | 83.8K | $720K | $8.59 | Dec 15, 2023 | Direct |
Oric Pharmaceuticals, Inc. | Chief Financial Officer | Restricted Stock Unit | 30K | $258K | $8.59 | Jan 2, 2024 | Direct |
Oric Pharmaceuticals, Inc. | Chief Financial Officer | Stock Option (right to buy) | 180K | Jan 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ORIC | Oric Pharmaceuticals, Inc. | Jan 2, 2024 | 2 | $0 | 4 | Jan 3, 2024 | Chief Financial Officer |
ORIC | Oric Pharmaceuticals, Inc. | Dec 15, 2023 | 4 | -$45.3K | 4 | Dec 19, 2023 | Chief Financial Officer |
ORIC | Oric Pharmaceuticals, Inc. | Feb 1, 2023 | 2 | $0 | 4 | Feb 2, 2023 | Chief Financial Officer |
ORIC | Oric Pharmaceuticals, Inc. | Dec 15, 2022 | 1 | -$6.85K | 4/A | Feb 17, 2023 | Chief Financial Officer |
ORIC | Oric Pharmaceuticals, Inc. | Jul 20, 2022 | 8 | $0 | 4 | Jul 21, 2022 | Chief Financial Officer |
ORIC | Oric Pharmaceuticals, Inc. | Mar 31, 2022 | 1 | $322K | 4 | Mar 31, 2022 | Chief Financial Officer |
ORIC | Oric Pharmaceuticals, Inc. | Feb 1, 2022 | 2 | $0 | 4 | Feb 2, 2022 | Chief Financial Officer |